Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CVS Caremark
Payers
CVS cuts 2024 outlook amid rise in medical costs in Q4
The healthcare giant expects at least $8.30 in earnings per share for this year, down from its previous projections of at least $8.50.
Frank Diamond
Feb 7, 2024 9:05am
CVS Health rolls out 'cost plus' model for drug pricing
Dec 5, 2023 12:00pm
Surescripts buys ActiveRADAR for therapeutic alternatives data
Nov 6, 2023 6:00pm
'Podnosis': Shifting away from the traditional PBM relationship
Nov 1, 2023 9:03am
Expert: Surescripts settlement didn't go far enough
Oct 6, 2023 10:05am
New AMA report slams PBM industry for lack of competition
Sep 12, 2023 4:50pm